MAximising Therapeutic Utility in Rheumatoid Arthritis
Highlights and News
- Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition - Frontiers
- Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition Frontiers
- Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue - Nature.com
- Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue Nature.com
- Rheumatoid arthritis - The Lancet
- Rheumatoid arthritis The Lancet
- Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges - Frontiers
- Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges Frontiers
- Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK - The BMJ
- Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK The BMJ
- Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial - Nature.com
- Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial Nature.com
- Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes - Nature.com
- Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes Nature.com
- Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy - Frontiers
- Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy Frontiers
- Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics - Nature.com
- Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics Nature.com
Related
- What is MATURA?
- EPIC-RA – Patient Survey
- Get Involved MPAG
- Highlights and News
The MATURA consortium includes academic groups and industry partners working together to identify and test biomarkers
predictive of response to biological therapy in patients with rheumatoid arthritis
predictive of response to biological therapy in patients with rheumatoid arthritis